Rotaru Vlad, Chitoran Elena, Gullo Giuseppe, Mosoiu Daniela Viorica, Simion Laurentiu
Medicine School, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
General Surgery and Surgical Oncology Department I, Bucharest Institute of Oncology "Prof. Dr. Al. Trestioreanu", 022328 Bucharest, Romania.
J Clin Med. 2025 Jun 18;14(12):4339. doi: 10.3390/jcm14124339.
The diagnosis of colorectal cancer in more advanced stages, especially in younger patients where the diagnosis usually occurs because of obstructive complications, has prompted the development of less invasive, more rapid and well tolerated methods of decompression as an alternative to the standard surgical approach. As such, self-expanding metal stents (SEMSs) have gained wide acceptance for the palliative alleviation of obstructive symptoms in patients with advanced colorectal cancer. The purpose of this study was to evaluate SEMS placement against various forms of palliative surgical procedures in terms of effectiveness, morbidity, mortality and oncologic results. We conducted a systematic search of PubMed, Web of Science, Cochrane Library and Medline for articles describing patients with incurable locally advanced obstructive colorectal cancer who underwent surgery or self-expanding metal stent placement as a palliative procedure for the alleviation of symptoms. Eighteen studies (1606 patients) were included in a pooled meta-analysis. In the surgery group the clinical success was slightly higher (98.62% vs. 94.92%; OR = 0.35, 95%CI [0.16-0.73], = 0.005) and the late complications rate was lower (13.9% vs. 24.0%; OR = 3.01, 95%CI [2.06-4.39], < 0.00001). The SEMS placement was associated with a lower early complication (11.3% vs. 28.1%; OR = 0.34, 95%CI [0.19-0.58], = 0.0001) and a shorter length of hospital stay (SMD = -1.94, 95%CI [-2.76, -1.12], < 0.00001). In terms of the oncologic results, surgery was significantly associated with an increased overall survival regardless of the type of procedure (OR = 1.24, 95%CI [1.08-1.42], = 0.002). Although having lower early morbidity and mortality rates, SEMS placement was associated with an increased chance of late complications and a worse overall survival, thus making them avoidable when patients have longer life expectancies. Due to the lower early complications rates, SEMSs might still have a place in the management of selected cases with bowel obstruction.
在结直肠癌更晚期阶段的诊断,尤其是在年轻患者中(这类患者通常因梗阻性并发症而被诊断),促使了开发侵入性更小、更快速且耐受性良好的减压方法,以替代标准手术方法。因此,自膨式金属支架(SEMS)已被广泛接受用于晚期结直肠癌患者梗阻症状的姑息性缓解。本研究的目的是在有效性、发病率、死亡率和肿瘤学结果方面,评估SEMS置入与各种形式的姑息性手术程序。我们对PubMed、科学网、Cochrane图书馆和Medline进行了系统检索,以查找描述患有无法治愈的局部晚期梗阻性结直肠癌且接受手术或自膨式金属支架置入作为缓解症状的姑息性程序的患者的文章。18项研究(1606例患者)被纳入汇总的荟萃分析。手术组的临床成功率略高(98.62%对94.92%;OR = 0.35,95%CI[0.16 - 0.73],P = 0.005),晚期并发症发生率较低(13.9%对24.0%;OR = 3.01,95%CI[2.06 - 4.39],P < 0.00001)。SEMS置入与较低的早期并发症相关(11.3%对28.1%;OR = 0.34,95%CI[0.19 - 0.58],P = 0.0001)以及较短的住院时间(SMD = -1.94,95%CI[-2.76,-1.12],P < 0.00001)。在肿瘤学结果方面,无论手术类型如何手术均与总体生存率增加显著相关(OR = 1.24,95%CI[1.08 - 1.42],P = 0.002)。尽管早期发病率和死亡率较低,但SEMS置入与晚期并发症几率增加及总体生存率较差相关,因此当患者预期寿命较长时应避免使用。由于早期并发症发生率较低,SEMS在某些肠梗阻病例的管理中可能仍有一席之地。